| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.423 | 25.297 | 26.657 | 31.604 | 27.056 | 21.713 | 25.926 | 34.623 | 36.330 | 31.623 |
| Total Income - EUR | 27.361 | 28.772 | 27.577 | 31.636 | 27.101 | 21.737 | 25.926 | 35.903 | 36.335 | 31.630 |
| Total Expenses - EUR | 27.014 | 26.947 | 26.018 | 25.650 | 28.139 | 17.939 | 27.418 | 35.005 | 28.423 | 32.831 |
| Gross Profit/Loss - EUR | 347 | 1.825 | 1.559 | 5.986 | -1.038 | 3.798 | -1.492 | 899 | 7.912 | -1.202 |
| Net Profit/Loss - EUR | -470 | 1.537 | 1.283 | 5.670 | -1.309 | 3.581 | -2.572 | 540 | 7.549 | -1.518 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Tipodoctor Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.130 | 3.749 | 920 | 892 | 2.851 | 3.235 | 3.256 | 4.129 | 4.260 | 2.982 |
| Current Assets | 31.149 | 17.523 | 18.156 | 13.503 | 14.074 | 10.443 | 15.153 | 11.694 | 16.946 | 15.941 |
| Inventories | 649 | 0 | 0 | 0 | 307 | 0 | 0 | 237 | 0 | 0 |
| Receivables | 8.045 | 6.865 | 9.278 | 2.845 | 6.604 | 4.631 | 5.292 | 4.613 | 5.340 | 7.625 |
| Cash | 22.456 | 10.658 | 8.878 | 10.658 | 7.163 | 5.812 | 9.861 | 6.843 | 11.606 | 8.315 |
| Shareholders Funds | 18.850 | 6.131 | 2.702 | 6.060 | 4.634 | 8.126 | 5.375 | 5.931 | 13.462 | 11.869 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 17.456 | 15.168 | 16.402 | 8.385 | 12.291 | 5.703 | 13.034 | 9.892 | 7.744 | 7.054 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2852 - 2852" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - Tipodoctor Srl